The time course of recovery of [3H~spiperone binding in the rat striatum after a single injection of the irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) shows that a slower rate of regeneration/turnover of D-2 dopamine receptors occurs in mid-lifemature versus young male rats. This slower receptor recovery reflects relatively slower rates of both receptor synthesis and degradation. Studies using cycloheximide indicate that protein synthesis plays a significant role in the reappearance of[FH]spiperone-binding sites. Other experiments indicate that chronic reserpine treatment, which produces dopamine receptor up regulation, also produces accelerated receptor recovery after EEDQ blockade. An age-related decline in dopamine receptor turnover, if present in humans and progressive into senescence, could be responsible for the increased risk of developing Parkinson disease and drug-induced parkinsonian-like extrapyramidal side effects with age. On the other hand, the more rapid receptor turnover rates seen in young rats may be a biochemical feature related to plasticity in the striatum during development.Age-related differences in therapeutic dosages and extrapyramidal side effects have been reported for the clinical use of antipsychotic drugs (1, 2). Since these agents are hypothesized to exert their therapeutic as well as extrapyramidal side effects by blocking dopamine receptors in the brain, one might expect the regulation of functional levels or other properties of these dopamine receptors to exhibit age-dependent differences. Indeed, dopamine receptor levels in rat striatum have been observed to increase over the first month postnatally (3), and age-correlated losses of dopaminergic receptor-binding activity and function have been noted in humans and rodents (for review, see refs. 2 and 4). In aged rodents relative deficits in the ability of dopamine receptors to exhibit up regulation in response to chronic dopamine receptor antagonist (antipsychotic) drug treatments have been described (5), although other researchers have not observed such aging-related deficits in dopamine receptor up regulation when more robust (lesion-induced) decreases in agonist input were used (6-9).Aging-related deficits in the ability of 83-adrenergic receptor to exhibit up regulation have also been described (10-12).A recent report described aging-related decreases in the regeneration of visceral beta-adrenergic receptors after their irreversible blockade (13), thus suggesting one possible mechanism for the observed age-related deficits in receptor up regulation. A vehicle and decapitated at various times. For time-course experiments, rats were sacrificed at the same time of day 6, 28-30, 52-54, 100-102, 148-150, and 172-174 hr after injection with either EEDQ or vehicle. Their brains were rapidly removed and placed in ice-cold saline, and their striata were dissected and stored frozen at -70'C for up to 6 days. An EEDQ dose of 8 mg/kg was chosen because it produced near maximal receptor blockade ...